Dr. Öğr. Üyesi MÜÇTEBA ENES YAYLA

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Rheumatoid Arthritis-Related Lung Disease and Its Association With Mortality

ŞAHİN EROĞLU D., ÇOLAKLAR A., Baysal S., Torgutalp M., BAYGÜL A., SEZER S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.30, sa.5, ss.177-182, 2024 (SCI-Expanded)

The factors predicting development of serious infections in ANCA-associated vasculitis

USLU YURTERİ E., Sezer S., Torgutalp M., YAYLA M. E., Eroglu D. S., Okatan I. E., et al.

Sarcoidosis Vasculitis and Diffuse Lung Diseases , cilt.40, sa.2, 2023 (SCI-Expanded)

Frequency of Helicobacter pylori in Patients With Rheumatoid Arthritis Whose Methotrexate Was Stopped Due to Gastrointestinal Intolerance

Aydemir Guloksuz E. G., Sezer S., YAYLA M. E., Sahin Eroglu D., USLU YURTERİ E., Kelesoglu Dincer A. B., et al.

Journal of Clinical Rheumatology , cilt.29, sa.4, ss.177-182, 2023 (SCI-Expanded)

Audiological involvement in patients with systemic sclerosis

Turan K., Yayla M. E., Arslan M., Tokgoz Yilmaz S., Okatan E., Turgay M., et al.

MODERN RHEUMATOLOGY , cilt.32, sa.6, ss.1094-1101, 2022 (SCI-Expanded)

Indications and risk factors for hospitalization in patients with primary Sjogren syndrome: experience from a tertiary center in Turkey

Yayla M. E., ŞAHİN EROĞLU D., USLU YURTERİ E., Dincer A. B. K., Sezer S., AYDEMİR GÜLÖKSÜZ E. G., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1457-1463, 2022 (SCI-Expanded)

Fetal exposure to canakinumab: a report of three pregnancies

Ilgen U., Eyupoglu S., Yayla M. E., KÜÇÜKŞAHİN O.

CLINICAL RHEUMATOLOGY , cilt.41, sa.4, ss.1261-1263, 2022 (SCI-Expanded)

Prognostic factors for relapse and poor outcome in neuro-Behcet's syndrome: results from a clinical long-term follow-up of a single centre

ŞAHİN EROĞLU D., Torgutalp M., YÜCESAN C., Sezer S., Yayla M. E., BOYVAT A., et al.

JOURNAL OF NEUROLOGY , cilt.269, sa.4, ss.2046-2054, 2022 (SCI-Expanded)

Analysis of vascular involvement in 460 patients with Behc , et's syndrome: Clinical characteristics and associated factors

Torgutalp M., Şahin Eroğlu D., Sezer S., Yayla M. E., Karataş G., Uslu Yurteri E., et al.

JOINT BONE SPINE , cilt.89, sa.2, 2022 (SCI-Expanded)

Can Subclinical Atherosclerosis Be Assessed More Precisely in Behcet Syndrome Patients by Using a Particular Cutoff Value for Carotid Intima Media Thickness?

Uslu Yurteri E., Üstüner E., Torgutalp M., Yayla M. E., Okatan I. E., Sezer S., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.28, sa.1, 2022 (SCI-Expanded)

Causes of severe infections in patients with systemic sclerosis and associated factors

YAYLA M. E., USLU YURTERİ E., USLU YURTERİ E., Sahin D., Sezer S., Dincer A. B. K., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.6, ss.1881-1888, 2022 (SCI-Expanded)

Patients characteristics in Behcet's Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases

Torgutalp M., Eroglu D. S., Sezer S., Yayla M. E., Karatas G., Ozel E. M., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.51, sa.1, ss.50-58, 2022 (SCI-Expanded)

RITUXIMAB EXPERIENCE FROM A SINGLE CENTRE FOR PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

Eroglu D. S., Colaklar A., Baysal S., Torgutalp M., Baygul A., YAYLA M. E., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.39, sa.3, 2022 (SCI-Expanded)

Clinical characteristics of pulmonary artery involvement in patients with Behcet's syndrome: single-centre experience of 61 patients

ŞAHİN EROĞLU D., Torgutalp M., Baysal S., ÇOLAKLAR A., Sezer S., Yayla M. E., et al.

CLINICAL RHEUMATOLOGY , cilt.40, sa.10, ss.4127-4134, 2021 (SCI-Expanded)

The Importance of Lower Extremity Vein Wall Thickness in Patients with Behcet's Syndrome

Kocabay H. E., YAYLA M. E., ÜSTÜNER E., Yurteri E. U., Guloksuz E. A., Sezer S., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.3915-3917, 2021 (SCI-Expanded)

Serum-Beta-2-Mikroglobulin-level bei Patienten mit rheumatoider Arthritis und ihre Beziehung zur Krankheitsaktivitat: Kann es als Krankheitsaktivitatsmarker verwendet werden?

Dincer A. B. K., Torgutalp M., Yayla M. E., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., USLU YURTERİ E., et al.

AKTUELLE RHEUMATOLOGIE , cilt.46, sa.3, ss.297-304, 2021 (SCI-Expanded)

High mobility group box-1 levels may be associated with disease activity of Behcet's disease

Donmez Guler D., Kelesoglu Dincer A. B., KARAHAN Z. C., Guler H. S., Yayla M. E., Sezer S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2690-2697, 2021 (SCI-Expanded)

Early onset primary Sjogren syndrome, clinical and laboratory characteristics

Yayla M. E., Karaman Z., Torgutalp M., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., Sezer S., et al.

CLINICAL RHEUMATOLOGY , cilt.39, sa.9, ss.2689-2696, 2020 (SCI-Expanded)

Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features

Yayla M. E., Torgutalp M., Okatan I. E., USLU YURTERİ E., KÜÇÜKŞAHİN O., Dincer A. B. K., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.26, sa.3, ss.83-86, 2020 (SCI-Expanded)

Vascular Involvement in Behcet's Syndrome May be Associated with Subclinical Atherosclerosis

USLU YURTERİ E., ÜSTÜNER E., Torgutalp M., Yayla M. E., Okatan I. E., Dincer A. B. K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded)

Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus

Ilgen U., Yayla M. E., Ates A., Okatan I. E., Yurteri E., Torgutalp M., et al.

LUPUS , sa.4, ss.665-669, 2018 (SCI-Expanded)

An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis

Yayla M. E., Ilgen U., Duzgun N.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.1, ss.10-15, 2018 (SCI-Expanded)

Anti-angiotensin II type 1 receptor autoantibodies (AT(1)R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations

Ilgen U., Yayla M. E., Duzgun N.

RHEUMATOLOGY INTERNATIONAL , cilt.37, sa.4, ss.593-598, 2017 (SCI-Expanded)

Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis

Ilgen U., Yayla M. E., Duzgun N.

CLINICAL RHEUMATOLOGY , cilt.36, sa.2, ss.367-372, 2017 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study Niveles séricos del factor inhibidor de la leucemia en pacientes con arteritis de Takayasu y de células gigantes, un estudio transversal

Aksoy R., TURGAY T. M., YILMAZ R., SEZER S., YAYLA M. E., USLU E.

Reumatologia Clinica , cilt.20, sa.6, ss.287-290, 2024 (ESCI)

Investigation of COVID-19 Vaccination and Disease Status in Behçet’s Patients

Yılmaz R., Sezer S., İlbay A., Göveç Gıynaş N., Aydemir Gülöksüz E. G., Gaydan A., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.76, sa.3, ss.206-212, 2023 (Hakemli Dergi)

Interstitial Lung Disease in Systemic Sclerosis: A Single-center Retrospective Analysis

Yayla M. E., Balci G., USLU YURTERİ E., ŞAHİN EROĞLU D., Dincer A. B. K., AYDEMİR GÜLÖKSÜZ E. G., et al.

CURRENT RHEUMATOLOGY REVIEWS , cilt.18, sa.2, ss.150-156, 2022 (ESCI)

Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels

Torgutalp M., Yayla M. E., Eroglu D. S., Dincer A. B. K., Yurteri E., Okatan I. E., et al.

Mediterranean Journal of Rheumatology , cilt.32, sa.1, ss.56-65, 2021 (Scopus) Sürdürülebilir Kalkınma

İdiyopatik retroperitoneal fibrozis: 17 olguluk tek merkez deneyimi

Keleşoğlu Dinçer A. B., Sezer S., Aydemir Gülöksüz E. G., Yayla M. E., Torgutalp M., Turgay T. M., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.1, ss.22-26, 2020 (Hakemli Dergi)

A Rare Clinical Presentation of Behçet’s Disease with Life-Threatening Extensive Multiple Thrombosis and Recurrent Cardiac Arrest

Shimbori N., YAYLA M. E., YILDIZ A. E., Keleş Karahacıoğlu D., DÜZGÜN N.

Türkiye Klinikleri Journal of Case Reports , cilt.26, sa.3, ss.161-165, 2018 (Hakemli Dergi)

Metrikler

Yayın

Atıf (WoS)

150

H-İndeks (WoS)

Atıf (Scopus)

146

H-İndeks (Scopus)

Atıf (Scholar)

149

H-İndeks (Scholar)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler